Post-earnings recap
Reported
Thu, Aug 6, 2026
EPS actual
$0.07
EPS est.
$-0.16
EPS surprise
+143.75%
1-day move
+22.49%
Delcath Systems, Inc. is a healthcare company focused on developing innovative treatments for cancer. Operating in the health care equipment sector, it aims to improve patient outcomes through its specialized medical technologies.
Last quarter
In Q1 2026, Delcath reported an EPS of -$0.03, missing estimates by a significant margin. The stock reacted negatively, declining by 0.18% the following day.
EPS beat streak
1Q
EPS beat rate
38%
Avg EPS surprise
+3.32%
Avg 1-day reaction
+3.77%
Overall expectations for Delcath's upcoming earnings are uncertain, especially given the mixed performance in previous quarters. Investors are keen to see if the company can turn around its recent trend of EPS misses.
Bull case
If Delcath can show improved revenue growth and better-than-expected EPS, it could signal a recovery and boost investor confidence.
Bear case
Conversely, another earnings miss could reinforce concerns about the company's financial health and lead to further stock declines.
The print will turn on these.
Q1
What is the expected revenue growth for the upcoming quarter?
Revenue growth will be a crucial indicator of the company's ability to recover from previous earnings misses.
Q2
How is Delcath managing its cash burn rate?
Understanding the cash burn rate will help investors assess the company's financial sustainability and future funding needs.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Why consensus could be wrong
The Street may be underestimating Delcath's potential for revenue recovery based on recent product developments and market demand.
Supporting evidence
The options market is pricing a 17.01% move, indicating expectations for significant volatility.
Historical patterns show that the stock often rebounds after a string of misses, suggesting potential for a positive surprise.
Key risk
If revenue growth exceeds expectations significantly, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is crucial as it follows a pattern of missed earnings expectations, and investors are looking for signs of recovery.
Bull confirmed if
A revenue growth of over 10% compared to the previous quarter would confirm the bull case.
Bear confirmed if
If the EPS comes in worse than -$0.05, it would confirm the bear case.
What the market is pricing for the move.
Implied Move
±17.01%
Historical Avg
±8.3%
The options market is pricing in a significant move, indicating that traders expect volatility around the earnings announcement.
Options are pricing ±17.0% while DCTH has averaged ±8.3% over the last 8 prints — setup is pricing rich.
ATM IV
1.1%
30d HV
42.6%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Delcath beats expectations, history suggests the stock could rise by around 5.82%, confirming a positive turnaround.
In line / cautious
If results are in line but cautious, the stock may see muted movement as investors await further clarity.
Miss
If the company misses again, history suggests a potential decline of about 6.09%, raising concerns about its financial health.
The lines on the call that would change the story.